Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case

Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case

ABSTRACT: We present two Delta (B.1.617.2) vaccine breakthrough individuals, a father and son living in separate households. The older, 63-year-old patient's symptoms were severe enough to require hospitalization. Despite having a high titer of anti-spike IgG in his serum, his symptoms resolved...

Full description

Bibliographic Details
Main Authors: Bradley A Connor, Mara Couto-Rodriguez, Joseph E Barrows, Morgan Gardner, Marina Rogova, Niamh B. O'Hara, Dorottya Nagy-Szakal
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:International Journal of Infectious Diseases
Subjects:
B.1.617.2
Delta variant
SARS-CoV-2
COVID-19
variant of concern
breakthrough
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221005865

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221005865

Similar Items